A widely available drug helps prevent upper gastrointestinal bleeding in critically ill adults on a breathing machine, according to the results of a global study and meta-analysis led by researchers ...

– Data Support the Ongoing Phase 3 STAR-221 Study of Domvanalimab Plus Zimberelimab and Chemotherapy, Potentially the First Anti-TIGIT Combination to Market for These Cancers – FOSTER CITY, Calif. & ...

A new study casts doubt on international guidelines advising up to a week of prophylactic antibiotics in patients with cirrhosis and upper gastrointestinal (GI) bleeding. Pooled data from 14 ...

WEST BRIDGEWATER, Mass.--(BUSINESS WIRE)--GI Windows, Inc., a clinical-stage medical device company, today announced the presentation of six-month results of the first-ever clinical study evaluating ...

Upper GI mucosal damage was tied to a 76% higher risk of subsequent Parkinson's disease. The retrospective study followed GI patients for nearly 15 years. The findings support literature suggesting ...

Please provide your email address to receive an email when new articles are posted on . Evidence for metoclopramide use in upper GI bleeding is very low, with few published trial data. Existing data ...

Researchers have identified eight primary factors that increase the risk of a common bleeding complication after heart attack. Some of these factors are already known, but using machine learning ...

Irinotecan plus S-1 (IRIS) versus S-1 alone as first line treatment for advanced gastric cancer: Preliminary results of a randomized phase III study (GC0301/TOP-002) No significant financial ...

Short-term use of selective serotonin reuptake inhibitors (SSRIs) for just 7 days may pose a significant increased risk for upper gastrointestinal (GI) bleeding, new research suggests. "Consistent ...